ACE-031

Also known as: ACE-031

An investigational myostatin-pathway blocker studied for muscle wasting.

⚕️ Educational reference only — not medical advice. Many peptides are not approved for human use and are sold for research purposes only. Always consult a qualified healthcare professional.

Overview

ACE-031 is an investigational decoy receptor designed to block myostatin and related signaling, studied by pharma for muscle-wasting conditions such as muscular dystrophy.

How It's Thought to Work

It acts as a soluble 'trap' for myostatin and related proteins, removing their restraint on muscle growth.

What the Research Says

Human trials were conducted but development was halted over safety signals (e.g., bleeding-related and vascular findings).

Regulatory & Legal Status

Investigational — not approved; clinical development was discontinued. Prohibited in sport by WADA.

Safety Considerations

Trials raised safety concerns; not an approved medicine. Consult a qualified clinician.

Frequently Asked Questions

What is ACE-031?

ACE-031 is an investigational decoy receptor designed to block myostatin and related signaling, studied by pharma for muscle-wasting conditions such as muscular dystrophy.

How does ACE-031 work?

It acts as a soluble 'trap' for myostatin and related proteins, removing their restraint on muscle growth.

What does the research say about ACE-031?

Human trials were conducted but development was halted over safety signals (e.g., bleeding-related and vascular findings).

Is ACE-031 FDA-approved or legal to buy?

Investigational — not approved; clinical development was discontinued. Prohibited in sport by WADA.

Is ACE-031 safe? What are the risks?

Trials raised safety concerns; not an approved medicine. Consult a qualified clinician.

On the Podcasts

The Science of Peptide-Based Myostatin Inhibitors: Can We Unlock More Muscle?

Want the latest on ACE-031 as it publishes?

Browse Research All Peptide Guides